RetinalGenix Technologies Inc.
RTGNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for RTGN. That does not mean none is planned.
Get an email about RTGN's next catalysts
Track RetinalGenix Technologies (RTGN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
N-acetylcysteine
Retinitis Pigmentosa
ketoconazole
Chronic Central Serous Chorioretinopathy
Anecortave Acetate Sterile
Chronic Central Serous Chorioretinopathy
Metformin
Age-Related Macular Degeneration
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
N-acetylcysteine | Phase 3 | Retinitis Pigmentosa | - | - |
ketoconazole | Phase 2 | Chronic Central Serous Chorioretinopathy | - | - |
Anecortave Acetate Sterile | Phase 2 | Chronic Central Serous Chorioretinopathy | - | - |
Metformin | Phase 2 | Age-Related Macular Degeneration | - | - |
Frequently asked questions
What is in RetinalGenix Technologies Inc.'s drug pipeline?β
CatalystAlert tracks 4 drug candidates in RetinalGenix Technologies Inc.'s (RTGN) pipeline across Phase 3, Phase 2. Its lead program is N-acetylcysteine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is RetinalGenix Technologies Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for RetinalGenix Technologies Inc. (RTGN) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track RTGN biotech catalysts?β
Add RTGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow RetinalGenix Technologies Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
